Daniel J. Trepanier

545 total citations
22 papers, 441 citations indexed

About

Daniel J. Trepanier is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Daniel J. Trepanier has authored 22 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Daniel J. Trepanier's work include Signaling Pathways in Disease (8 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (6 papers). Daniel J. Trepanier is often cited by papers focused on Signaling Pathways in Disease (8 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (6 papers). Daniel J. Trepanier collaborates with scholars based in Canada, United States and Sweden. Daniel J. Trepanier's co-authors include Randall W. Yatscoff, Daren Ure, Robert T. Foster, Donald F. LeGatt, Udayan Chatterji, Michael Bobardt, Philippe Gallay, R.J. Thibert, Patrick Mayo and Derrick G. Freitag and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Daniel J. Trepanier

22 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel J. Trepanier Canada 11 177 116 71 68 62 22 441
Joanne B. Allen United States 8 465 2.6× 83 0.7× 104 1.5× 92 1.4× 19 0.3× 9 749
Marzia Mare Italy 13 140 0.8× 66 0.6× 61 0.9× 70 1.0× 41 0.7× 30 448
Lei Dou China 12 123 0.7× 55 0.5× 54 0.8× 60 0.9× 16 0.3× 18 395
Francesco Guzzi Italy 13 240 1.4× 29 0.3× 14 0.2× 82 1.2× 31 0.5× 18 494
Xiaoli Yang China 14 169 1.0× 81 0.7× 9 0.1× 58 0.9× 12 0.2× 46 539
Chih‐Che Lin Taiwan 15 89 0.5× 290 2.5× 335 4.7× 151 2.2× 19 0.3× 42 614
Shaojie Yu China 12 129 0.7× 47 0.4× 6 0.1× 64 0.9× 41 0.7× 39 397
Gary Klein United States 9 212 1.2× 88 0.8× 57 0.8× 25 0.4× 2 0.0× 19 539
Kyla M. Smith Canada 15 238 1.3× 69 0.6× 11 0.2× 35 0.5× 67 1.1× 19 755
Anna Sinistro Italy 12 72 0.4× 146 1.3× 91 1.3× 24 0.4× 4 0.1× 15 875

Countries citing papers authored by Daniel J. Trepanier

Since Specialization
Citations

This map shows the geographic impact of Daniel J. Trepanier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Trepanier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Trepanier more than expected).

Fields of papers citing papers by Daniel J. Trepanier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Trepanier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Trepanier. The network helps show where Daniel J. Trepanier may publish in the future.

Co-authorship network of co-authors of Daniel J. Trepanier

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Trepanier. A scholar is included among the top collaborators of Daniel J. Trepanier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Trepanier. Daniel J. Trepanier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayo, Patrick, et al.. (2022). Effect of a High‐Fat Meal on Single‐Dose Rencofilstat (CRV431) Oral Bioavailability in Healthy Human Subjects. Clinical Pharmacology in Drug Development. 12(3). 287–293. 2 indexed citations
2.
Harrison, Stephen A., et al.. (2022). Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single‐blind, placebo‐controlled study in F2/F3 NASH. Hepatology Communications. 6(12). 3379–3392. 21 indexed citations
3.
Kuo, Joseph, Michael Bobardt, Udayan Chatterji, et al.. (2019). A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models. Journal of Pharmacology and Experimental Therapeutics. 371(2). 231–241. 41 indexed citations
4.
Gallay, Philippe, Daren Ure, Michael Bobardt, et al.. (2019). The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice. PLoS ONE. 14(6). e0217433–e0217433. 32 indexed citations
5.
Ure, Daren, Daniel J. Trepanier, Patrick Mayo, & Robert T. Foster. (2019). Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis (NASH). Expert Opinion on Investigational Drugs. 29(2). 163–178. 23 indexed citations
6.
Trepanier, Daniel J., Daren Ure, & Robert T. Foster. (2018). Development, Characterization, and Pharmacokinetic Evaluation of a CRV431 Loaded Self-Microemulsifying Drug Delivery System. Journal of Pharmacy & Pharmaceutical Sciences. 21(1s). 335s–348s. 12 indexed citations
7.
Conover, Michael R., et al.. (2018). Pharmacokinetic-pharmacodynamic modeling of Tenofovir Exalidex in HBV subjects. Journal of Hepatology. 68. S522–S522. 2 indexed citations
8.
Trepanier, Daniel J., Daren Ure, & Robert T. Foster. (2017). In Vitro Phase I Metabolism of CRV431, a Novel Oral Drug Candidate for Chronic Hepatitis B. Pharmaceutics. 9(4). 51–51. 9 indexed citations
9.
Foster, Robert T., Daren Ure, Daniel J. Trepanier, & Philippe Gallay. (2017). The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication. Journal of Hepatology. 66(1). S699–S699. 2 indexed citations
10.
Gallay, Philippe, Michael Bobardt, Udayan Chatterji, et al.. (2015). The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action. PLoS ONE. 10(8). e0134707–e0134707. 32 indexed citations
11.
Schinke, Robert J., et al.. (2014). Psychological support for the Canadian Olympic Boxing Team in meta-transitions through the National Team Program. International Journal of Sport and Exercise Psychology. 13(1). 74–89. 38 indexed citations
12.
Maksymowych, Walter P., Gian S. Jhangri, Launa J. Aspeslet, et al.. (2002). Amelioration of accelerated collagen induced arthritis by a novel calcineurin inhibitor, ISA(TX)247.. PubMed. 29(8). 1646–52. 9 indexed citations
13.
Trepanier, Daniel J., et al.. (2000). Pharmacokinetics and Metabolism of Sirolimus. Therapeutic Drug Monitoring. 22(1). 31–35. 41 indexed citations
14.
Trepanier, Daniel J., Mark D. Abel, Derrick G. Freitag, & Randall W. Yatscoff. (1999). Study of FK-binding Protein:FK506-metabolite Complexes by Electrospray Mass Spectrometry: Correlation to Immunosuppressive Activity. Therapeutic Drug Monitoring. 21(3). 274–274. 2 indexed citations
15.
Trepanier, Daniel J., et al.. (1998). Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update. Clinical Biochemistry. 31(5). 345–351. 109 indexed citations
16.
Jortani, Saeed A., Daniel J. Trepanier, Randall W. Yatscoff, & Roland Valdes. (1997). Convergence of Three Methods to Resolve Discrepant Immunoassay Digitoxin Results. Clinical Chemistry. 43(9). 1805–1808. 10 indexed citations
17.
Trepanier, Daniel J. & R.J. Thibert. (1996). Carbamylation of erythrocyte membrane aminophospholipids: an in vitro and in vivo study. Clinical Biochemistry. 29(4). 333–345. 14 indexed citations
18.
Trepanier, Daniel J., et al.. (1996). Carbamylation of erythrocyte membrane proteins: an in vitro and in vivo study. Clinical Biochemistry. 29(4). 347–355. 26 indexed citations
19.
Trepanier, Daniel J., et al.. (1995). Carbamylation of normal and uremic erythrocyte membrane protein. Clinical Biochemistry. 28(3). 332–332. 1 indexed citations
20.
Trepanier, Daniel J., Christopher Kevin Wong, & M.J. Kornblatt. (1990). The salt-induced dissociation and inactivation of a mammalian enolase: Evidence for the formation of active monomers. Archives of Biochemistry and Biophysics. 283(2). 271–277. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanne B. Allen Breakdown of academic impact, for papers by Marzia Mare Breakdown of academic impact, for papers by Lei Dou Breakdown of academic impact, for papers by Francesco Guzzi Breakdown of academic impact, for papers by Xiaoli Yang Breakdown of academic impact, for papers by Chih‐Che Lin Breakdown of academic impact, for papers by Shaojie Yu Breakdown of academic impact, for papers by Gary Klein Breakdown of academic impact, for papers by Kyla M. Smith Breakdown of academic impact, for papers by Anna Sinistro
Rankless by CCL
2026